Citigroup Maintains Buy on Boston Scientific, Lowers Price Target to $61

Benzinga · 1d ago
Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $70 to $61.